Table 2.
Haplotype Name | Haplotype SNP Compositiona | Affected patients (n=3) | Controls (n=4062) | Fisher’s exact test P-valueb |
Permutation P-valuec |
||
---|---|---|---|---|---|---|---|
Count | Percent (%) | Count | Percent (%) | ||||
Haplotype A | 2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2-2-2-1 | 1 | 16.67 | 644 | 7.93 | 0.3911 | |
Haplotype B* | 2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2-2 | 4 | 66.67 | 287 | 3.53 | 2.28x10-5 | < 10-6 |
Haplotype C | 2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-1-2-1-2-1-1-1-2-2-2-2-2-2-2-2-2-2-2-2-1 | 1 | 16.67 | 264 | 3.25 | 0.18036 | |
Haplotype D | 2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1 | 0 | 0 | 155 | 1.91 | ||
Haplotype E | 2-2-2-1-1-2-1-2-2-2-1-1-1-2-2-2-2-1-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2 | 0 | 0 | 62 | 0.76 | ||
Haplotype F | 2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2-2-2-2-2-2-2-2-2-2 | 0 | 0 | 49 | 0.60 | ||
Haplotype G | 2-2-2-2-1-2-2-1-2-2-2-2-2-2-1-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2-2-2-1 | 0 | 0 | 48 | 0.59 | ||
Haplotype H | 2-2-2-2-1-2-2-1-2-2-2-2-2-2-1-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2 | 0 | 0 | 13 | 0.16 | ||
Haplotype I | 2-2-2-2-1-2-2-1-2-2-2-2-2-2-1-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-1-2-2-2-2-2 | 0 | 0 | 7 | 0.09 | ||
Haplotype J | 2-2-2-1-1-2-1-2-2-2-2-2-2-2-2-2-2-2-1-1-2-2-1-2-2-2-1-2-1-2-2-2-2-2-2-2-2-1-2-2 | 0 | 0 | 2 | 0.02 |
aSNP allele “2”: major allele; SNP allele “1”: minor allele.
bComparisons of haplotype frequencies between affected patients and controls using Fisher’s exact test.
cComparison of frequencies of haplotype B between affected patients and controls using permutation test, permutation time=1000000.
*Common haplotype among affected patients.